Request for Covid-19 Impact Assessment of this Report
The United States Oral Cholera Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Cholera Vaccine market, reaching US$ million by the year 2028. As for the Europe Oral Cholera Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Cholera Vaccine players cover PaxVax, Sanofi, Valneva, and EuBiologics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Cholera Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Shanchol
Dukoral
Vaxchora
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
PaxVax
Sanofi
Valneva
EuBiologics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Cholera Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Cholera Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Cholera Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Oral Cholera Vaccine Segment by Type
2.2.1 Shanchol
2.2.2 Dukoral
2.2.3 Vaxchora
2.2.4 Others
2.3 Oral Cholera Vaccine Sales by Type
2.3.1 Global Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Cholera Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Cholera Vaccine Sale Price by Type (2017-2022)
2.4 Oral Cholera Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research & Academic Laboratories
2.4.3 Pharmaceutical & Biotechnology Companies
2.4.4 Others
2.5 Oral Cholera Vaccine Sales by Application
2.5.1 Global Oral Cholera Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Cholera Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Cholera Vaccine Sale Price by Application (2017-2022)
3 Global Oral Cholera Vaccine by Company
3.1 Global Oral Cholera Vaccine Breakdown Data by Company
3.1.1 Global Oral Cholera Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Oral Cholera Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Oral Cholera Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Cholera Vaccine Revenue by Company (2020-2022)
3.2.2 Global Oral Cholera Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Oral Cholera Vaccine Sale Price by Company
3.4 Key Manufacturers Oral Cholera Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Cholera Vaccine Product Location Distribution
3.4.2 Players Oral Cholera Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Cholera Vaccine by Geographic Region
4.1 World Historic Oral Cholera Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Cholera Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Cholera Vaccine Annual Revenue by Geographic Region
4.2 World Historic Oral Cholera Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Cholera Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Cholera Vaccine Annual Revenue by Country/Region
4.3 Americas Oral Cholera Vaccine Sales Growth
4.4 APAC Oral Cholera Vaccine Sales Growth
4.5 Europe Oral Cholera Vaccine Sales Growth
4.6 Middle East & Africa Oral Cholera Vaccine Sales Growth
5 Americas
5.1 Americas Oral Cholera Vaccine Sales by Country
5.1.1 Americas Oral Cholera Vaccine Sales by Country (2017-2022)
5.1.2 Americas Oral Cholera Vaccine Revenue by Country (2017-2022)
5.2 Americas Oral Cholera Vaccine Sales by Type
5.3 Americas Oral Cholera Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Cholera Vaccine Sales by Region
6.1.1 APAC Oral Cholera Vaccine Sales by Region (2017-2022)
6.1.2 APAC Oral Cholera Vaccine Revenue by Region (2017-2022)
6.2 APAC Oral Cholera Vaccine Sales by Type
6.3 APAC Oral Cholera Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Cholera Vaccine by Country
7.1.1 Europe Oral Cholera Vaccine Sales by Country (2017-2022)
7.1.2 Europe Oral Cholera Vaccine Revenue by Country (2017-2022)
7.2 Europe Oral Cholera Vaccine Sales by Type
7.3 Europe Oral Cholera Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Cholera Vaccine by Country
8.1.1 Middle East & Africa Oral Cholera Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Cholera Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Cholera Vaccine Sales by Type
8.3 Middle East & Africa Oral Cholera Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Cholera Vaccine
10.3 Manufacturing Process Analysis of Oral Cholera Vaccine
10.4 Industry Chain Structure of Oral Cholera Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Cholera Vaccine Distributors
11.3 Oral Cholera Vaccine Customer
12 World Forecast Review for Oral Cholera Vaccine by Geographic Region
12.1 Global Oral Cholera Vaccine Market Size Forecast by Region
12.1.1 Global Oral Cholera Vaccine Forecast by Region (2023-2028)
12.1.2 Global Oral Cholera Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Cholera Vaccine Forecast by Type
12.7 Global Oral Cholera Vaccine Forecast by Application
13 Key Players Analysis
13.1 PaxVax
13.1.1 PaxVax Company Information
13.1.2 PaxVax Oral Cholera Vaccine Product Offered
13.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 PaxVax Main Business Overview
13.1.5 PaxVax Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Oral Cholera Vaccine Product Offered
13.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Valneva
13.3.1 Valneva Company Information
13.3.2 Valneva Oral Cholera Vaccine Product Offered
13.3.3 Valneva Oral Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Valneva Main Business Overview
13.3.5 Valneva Latest Developments
13.4 EuBiologics
13.4.1 EuBiologics Company Information
13.4.2 EuBiologics Oral Cholera Vaccine Product Offered
13.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 EuBiologics Main Business Overview
13.4.5 EuBiologics Latest Developments
14 Research Findings and Conclusion
Table 1. Oral Cholera Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Cholera Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Shanchol
Table 4. Major Players of Dukoral
Table 5. Major Players of Vaxchora
Table 6. Major Players of Others
Table 7. Global Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 8. Global Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
Table 9. Global Oral Cholera Vaccine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Oral Cholera Vaccine Revenue Market Share by Type (2017-2022)
Table 11. Global Oral Cholera Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 13. Global Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
Table 14. Global Oral Cholera Vaccine Revenue by Application (2017-2022)
Table 15. Global Oral Cholera Vaccine Revenue Market Share by Application (2017-2022)
Table 16. Global Oral Cholera Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Oral Cholera Vaccine Sales by Company (2020-2022) & (K Units)
Table 18. Global Oral Cholera Vaccine Sales Market Share by Company (2020-2022)
Table 19. Global Oral Cholera Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Oral Cholera Vaccine Revenue Market Share by Company (2020-2022)
Table 21. Global Oral Cholera Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Oral Cholera Vaccine Producing Area Distribution and Sales Area
Table 23. Players Oral Cholera Vaccine Products Offered
Table 24. Oral Cholera Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Oral Cholera Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Oral Cholera Vaccine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Oral Cholera Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Oral Cholera Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Oral Cholera Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Oral Cholera Vaccine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Oral Cholera Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Oral Cholera Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Americas Oral Cholera Vaccine Sales Market Share by Country (2017-2022)
Table 37. Americas Oral Cholera Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Oral Cholera Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Americas Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Americas Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
Table 41. Americas Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 42. Americas Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
Table 43. APAC Oral Cholera Vaccine Sales by Region (2017-2022) & (K Units)
Table 44. APAC Oral Cholera Vaccine Sales Market Share by Region (2017-2022)
Table 45. APAC Oral Cholera Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Oral Cholera Vaccine Revenue Market Share by Region (2017-2022)
Table 47. APAC Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 48. APAC Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
Table 49. APAC Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. APAC Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
Table 51. Europe Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 52. Europe Oral Cholera Vaccine Sales Market Share by Country (2017-2022)
Table 53. Europe Oral Cholera Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Oral Cholera Vaccine Revenue Market Share by Country (2017-2022)
Table 55. Europe Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 56. Europe Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
Table 57. Europe Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 58. Europe Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oral Cholera Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Oral Cholera Vaccine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Oral Cholera Vaccine
Table 68. Key Market Challenges & Risks of Oral Cholera Vaccine
Table 69. Key Industry Trends of Oral Cholera Vaccine
Table 70. Oral Cholera Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Oral Cholera Vaccine Distributors List
Table 73. Oral Cholera Vaccine Customer List
Table 74. Global Oral Cholera Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Oral Cholera Vaccine Sales Market Forecast by Region
Table 76. Global Oral Cholera Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Oral Cholera Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Oral Cholera Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Oral Cholera Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Oral Cholera Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Oral Cholera Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Oral Cholera Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Oral Cholera Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Oral Cholera Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Oral Cholera Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Oral Cholera Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Oral Cholera Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Oral Cholera Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Oral Cholera Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Oral Cholera Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Oral Cholera Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Oral Cholera Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Oral Cholera Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 94. PaxVax Basic Information, Oral Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. PaxVax Oral Cholera Vaccine Product Offered
Table 96. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. PaxVax Main Business
Table 98. PaxVax Latest Developments
Table 99. Sanofi Basic Information, Oral Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Oral Cholera Vaccine Product Offered
Table 101. Sanofi Oral Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Valneva Basic Information, Oral Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Valneva Oral Cholera Vaccine Product Offered
Table 106. Valneva Oral Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Valneva Main Business
Table 108. Valneva Latest Developments
Table 109. EuBiologics Basic Information, Oral Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. EuBiologics Oral Cholera Vaccine Product Offered
Table 111. EuBiologics Oral Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. EuBiologics Main Business
Table 113. EuBiologics Latest Developments
List of Figures
Figure 1. Picture of Oral Cholera Vaccine
Figure 2. Oral Cholera Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Cholera Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Cholera Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Cholera Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Shanchol
Figure 10. Product Picture of Dukoral
Figure 11. Product Picture of Vaxchora
Figure 12. Product Picture of Others
Figure 13. Global Oral Cholera Vaccine Sales Market Share by Type in 2021
Figure 14. Global Oral Cholera Vaccine Revenue Market Share by Type (2017-2022)
Figure 15. Oral Cholera Vaccine Consumed in Hospital
Figure 16. Global Oral Cholera Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 17. Oral Cholera Vaccine Consumed in Research & Academic Laboratories
Figure 18. Global Oral Cholera Vaccine Market: Research & Academic Laboratories (2017-2022) & (K Units)
Figure 19. Oral Cholera Vaccine Consumed in Pharmaceutical & Biotechnology Companies
Figure 20. Global Oral Cholera Vaccine Market: Pharmaceutical & Biotechnology Companies (2017-2022) & (K Units)
Figure 21. Oral Cholera Vaccine Consumed in Others
Figure 22. Global Oral Cholera Vaccine Market: Others (2017-2022) & (K Units)
Figure 23. Global Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
Figure 24. Global Oral Cholera Vaccine Revenue Market Share by Application in 2021
Figure 25. Oral Cholera Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Oral Cholera Vaccine Revenue Market Share by Company in 2021
Figure 27. Global Oral Cholera Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Oral Cholera Vaccine Revenue Market Share by Geographic Region in 2021
Figure 29. Global Oral Cholera Vaccine Sales Market Share by Region (2017-2022)
Figure 30. Global Oral Cholera Vaccine Revenue Market Share by Country/Region in 2021
Figure 31. Americas Oral Cholera Vaccine Sales 2017-2022 (K Units)
Figure 32. Americas Oral Cholera Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. APAC Oral Cholera Vaccine Sales 2017-2022 (K Units)
Figure 34. APAC Oral Cholera Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Europe Oral Cholera Vaccine Sales 2017-2022 (K Units)
Figure 36. Europe Oral Cholera Vaccine Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Oral Cholera Vaccine Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Oral Cholera Vaccine Revenue 2017-2022 ($ Millions)
Figure 39. Americas Oral Cholera Vaccine Sales Market Share by Country in 2021
Figure 40. Americas Oral Cholera Vaccine Revenue Market Share by Country in 2021
Figure 41. United States Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Oral Cholera Vaccine Sales Market Share by Region in 2021
Figure 46. APAC Oral Cholera Vaccine Revenue Market Share by Regions in 2021
Figure 47. China Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Oral Cholera Vaccine Sales Market Share by Country in 2021
Figure 54. Europe Oral Cholera Vaccine Revenue Market Share by Country in 2021
Figure 55. Germany Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Oral Cholera Vaccine Revenue Market Share by Country in 2021
Figure 62. Egypt Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Oral Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Oral Cholera Vaccine in 2021
Figure 68. Manufacturing Process Analysis of Oral Cholera Vaccine
Figure 69. Industry Chain Structure of Oral Cholera Vaccine
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...